NAC and Glutathione

What are the safety, dosing, and pharmacokinetic limitations of high‑dose NAC for targeting intracellular glutathione in humans?

() can increase systemic cysteine availability and has a generally favorable safety profile in many clinical trials, but pharmacokinetic limits, route‑dependent adverse events, and uncertain translati...